Catálogo de publicaciones - revistas

<jats:p>President Barack Obama plans to ask Congress to cancel work on a new rocket and instead fund a heavy-lift launcher to take humans to the moon, asteroids, and the moons of Mars.</jats:p>

<jats:p>As hard as it was to negotiate a deal in Denmark, President Barack Obama faces an even tougher time in Washington trying to convince the U.S. Senate to pass cap-and-trade legislation. And he's up against a ticking clock: the November 2010 elections that will decide whether his party retains control of Congress.</jats:p>

<jats:p>Australian Synchrotron (AS) Director Robert Lamb and board members have refused to discuss details of his recent firing. But many observers say that a gaping rift developed between the board of directors on one hand and AS staff and the international scientific advisory committee on the other over the slow pace of developing long-term plans.</jats:p>

<jats:p> <jats:italic>Science</jats:italic> NOW reported last week that hand size, not sex, determines sense of touch; chimps can keep their cool around forest fires; controlling breathing can control seasickness; and bacteria can transform minerals electrically; among other stories. </jats:p>

<jats:p>Administrative changes and the ravages of the economy have left the Science and Technology Facilities Council, the British body responsible for particle physics, astronomy, nuclear physics, and space science, with a gaping hole in its finances. In the 5-year funding plan announced in mid-December, nuclear physics has been pared to the bone, with just £30 million for the next 5 years, amounting to a cut of 29% over that period.</jats:p>

<jats:p> Last week, <jats:italic>Science</jats:italic> published online an "Editorial Expression of Concern" noting that "serious questions have been raised about the methods and data presented" in the description of a newly developed research tool called a reactome array, which was published in the 9 October issue of <jats:italic>Science</jats:italic> . </jats:p>

<jats:p> <jats:italic>Science</jats:italic> Insider reported last week that Merck has hired the former director of the U.S. Centers for Disease Control and Prevention, Julie Gerberding, as its head of vaccine development and Henrik Thomsen, a Danish clinician who alerted patients and regulators to potential risks of Omniscan, a drug used to improve MRI scans, is facing a libel suit, among other stories. </jats:p>